Given that TNFα is able to upregulate Fas expression in human cancer cell lines and sensitize them to FasL-induced cell death [15-17], we sought to investigate whether TNFα and FasL combination could be therapeutically relevant in NBL. This evidence concerns the gene TNF and cancer.